What are Growth hormone analogue drugs?

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Growth hormone analogue drugs are pharmacologic agents that share a common mechanism (typically targeting Growth hormone receptor). 0 are currently marketed, with 2 more in clinical development.

Growth hormone analogue

0 marketed 1 in Phase 3 1 in Phase 2

This page covers all Growth hormone analogue drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Growth hormone receptor.

Targets

Growth hormone receptor

Phase 3 pipeline (1)

Saizen® A · Merck KGaA, Darmstadt, Germany · Endocrinology
Saizen A is a recombinant human growth hormone analogue used to treat growth hormone deficiency.

Phase 2 pipeline (1)

GH21 Capsule · Suzhou Genhouse Bio Co., Ltd. · Endocrinology
GH21 Capsule is a growth hormone analogue used to treat growth hormone deficiency.

Patent intelligence

growth hormone analogue patent landscape — aggregated cliff calendar, attackable patents, originator estates